Cefotiam therapy of lower respiratory tract infections.
Cefotiam, a new cephalosporin, was evaluated in the treatment of lower respiratory tract infections in 29 patients. The bacteria isolated from the sputum of these patients included Streptococcus pneumoniae (31%), Klebsiella pneumoniae (31%), and Haemophilus influenzae (28%). Satisfactory response wa...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1985
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180308/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3865632/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.28.4.576 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|